These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2770120)

  • 41. Rebound of plasma vancomycin levels after haemodialysis with highly permeable membranes.
    Böhler J; Reetze-Bonorden P; Keller E; Kramer A; Schollmeyer PJ
    Eur J Clin Pharmacol; 1992; 42(6):635-9. PubMed ID: 1623904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of hemodialysis with high-flux polysulfone membrane in the treatment of life-threatening methanol intoxication.
    Peces R; Alvarez R
    Nephron; 2002 Feb; 90(2):216-8. PubMed ID: 11818709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
    Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
    Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.
    Ljungberg B; Jacobson SH; Lins LE; Pejler G
    Clin Nephrol; 1992 Aug; 38(2):97-100. PubMed ID: 1325310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transport Characteristics of Asymmetric Cellulose Triacetate Hemodialysis Membranes.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Blood Purif; 2018; 45(1-3):46-52. PubMed ID: 29161718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of hemodialysis membranes on serum albumin.
    Locatelli F;
    Am J Kidney Dis; 2001 Feb; 37(2):455-6. PubMed ID: 11157397
    [No Abstract]   [Full Text] [Related]  

  • 47. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the effects of polysulfone and polyester-polymer alloy dialyzers on glycemic control in diabetic patients undergoing hemodialysis.
    Abe M; Okada K; Maruyama T; Ikeda K; Kikuchi F; Kaizu K; Matsumoto K
    Clin Nephrol; 2009 May; 71(5):514-20. PubMed ID: 19473611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vancomycin clearance with high-flux dialysis membranes.
    Anandan JV; Touchette MA
    Int J Artif Organs; 1998 Mar; 21(3):131-3. PubMed ID: 9622110
    [No Abstract]   [Full Text] [Related]  

  • 52. A study of the basic principles determining the performance of several high-flux dialyzers.
    Jindal KK; McDougall J; Woods B; Nowakowski L; Goldstein MB
    Am J Kidney Dis; 1989 Dec; 14(6):507-11. PubMed ID: 2688406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers.
    Molitoris BA; Alfrey AC; Alfrey PS; Miller NL
    Kidney Int; 1988 Jul; 34(1):98-101. PubMed ID: 3172641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disordered breathing patterns during bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone membranes.
    Navarro J; Serrano C; Donna E; Perez GO
    ASAIO J; 1992; 38(4):811-4. PubMed ID: 1450477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein catabolism in sham-hemodialysis: the effect of different membranes.
    Gutierrez A; Bergström J; Alvestrand A
    Clin Nephrol; 1992 Jul; 38(1):20-9. PubMed ID: 1499165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers.
    Floridi A; Piroddi M; Pilolli F; Matsumoto Y; Aritomi M; Galli F
    Acta Biomater; 2009 Oct; 5(8):2974-82. PubMed ID: 19442768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of peracetic acid reprocessing on the transport characteristics of polysulfone hemodialyzers.
    Wolff SH; Zydney AL
    Artif Organs; 2005 Feb; 29(2):166-73. PubMed ID: 15670286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteins adsorbed on hemodialysis membranes modulate neutrophil activation.
    Kuwahara T; Markert M; Wauters JP
    Artif Organs; 1989 Oct; 13(5):427-31. PubMed ID: 2803051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone.
    Amato M; Salvadori M; Bergesio F; Messeri A; Filimberti E; Morfini M
    Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.
    Welage LS; Mason NA; Hoffman EJ; Odeh RM; Dombrouski J; Patel JA; Swartz RD
    J Am Soc Nephrol; 1995 Oct; 6(4):1284-90. PubMed ID: 8589298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.